TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $744,401 | -1.5% | 48,119 | 0.0% | 0.19% | +1.6% |
| Q2 2023 | $755,949 | -8.5% | 48,119 | -4.0% | 0.19% | -11.2% |
| Q1 2023 | $825,961 | +5.6% | 50,119 | 0.0% | 0.22% | +1.4% |
| Q4 2022 | $781,856 | +19.7% | 50,119 | -0.4% | 0.21% | +6.0% |
| Q3 2022 | $653,000 | -7.5% | 50,319 | 0.0% | 0.20% | -5.7% |
| Q2 2022 | $706,000 | +5.2% | 50,319 | +7.4% | 0.21% | +11.6% |
| Q1 2022 | $671,000 | +44.9% | 46,869 | +38.0% | 0.19% | +35.7% |
| Q4 2021 | $463,000 | +17.8% | 33,969 | +41.7% | 0.14% | +5.3% |
| Q3 2021 | $393,000 | -2.5% | 23,966 | 0.0% | 0.13% | -4.3% |
| Q2 2021 | $403,000 | -8.0% | 23,966 | 0.0% | 0.14% | -15.8% |
| Q1 2021 | $438,000 | -3.9% | 23,966 | -4.3% | 0.16% | -7.8% |
| Q4 2020 | $456,000 | +3.9% | 25,041 | +1.8% | 0.18% | -16.0% |
| Q3 2020 | $439,000 | +2210.5% | 24,591 | +2262.2% | 0.21% | +2030.0% |
| Q2 2020 | $19,000 | +18.8% | 1,041 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $16,000 | -23.8% | 1,041 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $21,000 | +16.7% | 1,041 | 0.0% | 0.01% | +11.1% |
| Q3 2019 | $18,000 | 0.0% | 1,041 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $18,000 | -14.3% | 1,041 | 0.0% | 0.01% | -18.2% |
| Q1 2019 | $21,000 | – | 1,041 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |